1. Home
  2. SG vs SDGR Comparison

SG vs SDGR Comparison

Compare SG & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sweetgreen Inc.

SG

Sweetgreen Inc.

SELL

Current Price

$12.12

Market Cap

1.6B

ML Signal

SELL

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

SELL

Current Price

$27.39

Market Cap

1.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SG
SDGR
Founded
2007
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SG
SDGR
Price
$12.12
$27.39
Analyst Decision
Buy
Buy
Analyst Count
14
7
Target Price
$12.18
★ $33.57
AVG Volume (30 Days)
★ 4.9M
1.6M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.14
EPS
★ 0.57
N/A
Revenue
★ $679,474,000.00
$255,869,000.00
Revenue This Year
$3.01
N/A
Revenue Next Year
$7.35
N/A
P/E Ratio
$21.42
★ N/A
Revenue Growth
0.39
★ 23.29
52 Week Low
$4.49
$10.95
52 Week High
$13.89
$34.00

Technical Indicators

Market Signals
Indicator
SG
SDGR
Relative Strength Index (RSI) 58.62 47.78
Support Level $10.85 $11.65
Resistance Level N/A $32.15
Average True Range (ATR) 0.84 2.55
MACD -0.04 -0.01
Stochastic Oscillator 47.69 17.30

Price Performance

Historical Comparison
SG
SDGR

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Its menu involves, Kids' meal, salads, sides, local items, Protein Plates, Desserts, Drinks and Others.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: